Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway
Chenxiao Yu(Soochow University), Jianping Cao(Soochow University), Guangxia Chen(Xuzhou Medical College), Qi Zhang(Soochow University), Ligang Xing(Shandong University), Shuyu Zhang(Shanghai Jiao Tong University), Wei Zhu(Ministry of Education of the People's Republic of China), Yang Jiao(South China Institute of Collaborative Innovation), Jiao Xue(Jinzhou Medical University), Hongying Yang(Kunming Medical University), Jinchang Wu(Fudan University Shanghai Cancer Center)
Cited by 88
Related Papers
Redefining the invertebrate RNA virosphere
|Nature|2016|1.8k
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
|The Lancet|2023|676
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Tirzepatide for Obesity Treatment and Diabetes Prevention
|New England Journal of Medicine|2024|368